HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Free Full Text (PDF) Free All Versions of this Article: 102/1/261    most recent 00096.2006v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by Zhu, Y. Z. Articles by Moore, P. K. Search for Related Content PubMed PubMed Citation Articles by Zhu, Y. Z. Articles by Moore, P. K.

Hydrogen sulfide and its possible roles in myocardial ischemia in experimental rats

Departments of ¹Pharmacology and ²Biochemistry, National University of Singapore, Singapore; ³Departments of Physiology and Pathophysiology, and ⁴Pharmacology, School of Pharmacy and Institute of Biological Sciences, Fudan University, Shanghai, People's Republic of China; and ⁵Defence Medical and Environmental Research Institute, Singapore

Submitted 25 January 2006 ; accepted in final form 25 September 2006

The role of hydrogen sulfide (H₂S) in myocardial infarction (MI) has not been previously studied. We therefore investigated the effect of H₂S in a rat model of MI in vivo. Animals were randomly divided into three groups (n = 80) and received either vehicle, 14 µmol/kg of sodium hydrosulfide (NaHS), or 50 mg/kg propargylglycine (PAG) everyday for 1 wk before surgery, and the treatment was continued for a further 2 days after MI when the animals were killed. The mortality was 35% in vehicle-treated, 40% in PAG-treated, and 27.5% in NaHS-treated (P < 0.05 vs. vehicle) groups. Infarct size was 52.9 ± 3.5% in vehicle-treated, 62.9 ± 7.6% in PAG-treated, and 43.4 ± 2.8% in NaHS-treated (P < 0.05 vs. vehicle) groups. Plasma H₂S concentration was significantly increased after MI (59.2 ± 7.16 µM) compared with the baseline concentration (i.e., 38.2 ± 2.07 µM before MI; P < 0.05). Elevated plasma H₂S after MI was abolished by treatment of animals with PAG (39.2 ± 5.02 µM). We further showed for the first time cystathionine-gamma-lyase protein localization in the myocardium of the infarct area by using immunohistochemical staining. In the hypoxic vascular smooth muscle cells, we found that cell death was increased under the stimuli of hypoxia but that the increased cell death was attenuated by the pretreatment of NaHS (71 ± 1.2% cell viability in hypoxic vehicle vs. 95 ± 2.3% in nonhypoxic control; P < 0.05). In conclusion, endogenous H₂S was cardioprotective in the rat model of MI. PAG reduced endogenous H₂S production after MI by inhibiting cystathionine-gamma-lyase. The results suggest that H₂S might provide a novel approach to the treatment of MI.

cardioprotection; gasomediator; cardiac protection; ischemic animal model

This article has been cited by other articles:

				Q. C. Yong, S. W. Lee, C. S. Foo, K. L. Neo, X. Chen, and J.-S. Bian Endogenous hydrogen sulphide mediates the cardioprotection induced by ischemic postconditioning Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1330 - H1340. [Abstract] [Full Text] [PDF]

				Y.-G. Sun, Y.-X. Cao, W.-W. Wang, S.-F. Ma, T. Yao, and Y.-C. Zhu Hydrogen sulphide is an inhibitor of L-type calcium channels and mechanical contraction in rat cardiomyocytes Cardiovasc Res, September 1, 2008; 79(4): 632 - 641. [Abstract] [Full Text] [PDF]

				M. Bliksoen, M.-L. Kaljusto, J. Vaage, and K.-O. Stenslokken Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart. Eur. J. Cardiothorac. Surg., August 1, 2008; 34(2): 344 - 349. [Abstract] [Full Text] [PDF]

				N. L. Whitfield, E. L. Kreimier, F. C. Verdial, N. Skovgaard, and K. R. Olson Reappraisal of H2S/sulfide concentration in vertebrate blood and its potential significance in ischemic preconditioning and vascular signaling Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2008; 294(6): R1930 - R1937. [Abstract] [Full Text] [PDF]

				N. R. Sodha, R. T. Clements, J. Feng, Y. Liu, C. Bianchi, E. M. Horvath, C. Szabo, and F. W. Sellke The effects of therapeutic sulfide on myocardial apoptosis in response to ischemia-reperfusion injury Eur. J. Cardiothorac. Surg., May 1, 2008; 33(5): 906 - 913. [Abstract] [Full Text] [PDF]

				S. C. Chuah, P. K. Moore, and Y. Z. Zhu S-allylcysteine mediates cardioprotection in an acute myocardial infarction rat model via a hydrogen sulfide-mediated pathway Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2693 - H2701. [Abstract] [Full Text] [PDF]

				D. K. Das Hydrogen sulfide preconditioning by garlic when it starts to smell Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2629 - H2630. [Full Text] [PDF]